Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1501 - 1600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1501 | 26772303 |
US |
11 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1502 | 26772305 |
US |
1 | |
Dermatitis atopic, Off label use, Therapeutic response decreased, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 1503 | 26772312 |
US |
17 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1504 | 26772314 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1505 | 26772739 |
US |
38 | 1 |
Sleep disorder, Fatigue, Diarrhoea, Vision blurred, Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1506 | 26772746 |
US |
27 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1507 | 26772962 |
US |
17 | 1 |
Dermatitis atopic, Drug ineffective, |
||||
TRALOKINUMAB-LDRM, SERTRALINE, DOXEPIN, DOXEPIN HYDROCHLORIDE, |
||||
| 1508 | 26773122 |
US |
2 | |
Eyelid skin dryness, Erythema of eyelid, Ocular hyperaemia, Urticaria, Conjunctivitis, Dermatitis allergic, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1509 | 26773132 |
US |
64 | 1 |
Lacrimation increased, Dermatitis atopic, Rash, Dermatitis allergic, |
||||
DUPILUMAB, |
||||
| 1510 | 26773139 |
US |
2 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1511 | 26773152 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1512 | 26773184 |
US |
||
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1513 | 26773702 |
US |
16 | 1 |
Hypertension, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1514 | 26773709 |
US |
19 | 2 |
Dermatitis atopic, Dairy intolerance, |
||||
DUPILUMAB, |
||||
| 1515 | 26774054 |
US |
2 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1516 | 26774088 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1517 | 26774096 |
US |
4 | 1 |
Rash, Pruritus, Dermatitis atopic, Rash erythematous, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1518 | 26774100 |
US |
60 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1519 | 26774104 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1520 | 26774107 |
US |
2 | |
Dermatitis atopic, Pruritus, Eczema, |
||||
DUPILUMAB, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 1521 | 26774139 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1522 | 26774642 |
US |
63 | 2 |
Arthritis, Arthralgia, Condition aggravated, Therapeutic response shortened, Product use in unapproved indication, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ERGOCALCIFEROL, HYDROCORTISONE, ESCITALOPRAM, |
||||
| 1523 | 26774671 |
US |
22 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1524 | 26774673 |
US |
59 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, HYDROXYZINE, ROSUVASTATIN CALCIUM, |
||||
| 1525 | 26774679 |
US |
1 | |
Rash, Discomfort, Sleep disorder due to a general medical condition, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1526 | 26774977 |
US |
2 | |
Dermatitis atopic, Intentional product misuse, |
||||
DUPILUMAB, |
||||
| 1527 | 26774998 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1528 | 26775248 |
US |
79 | 2 |
Cardiac disorder, Sleep apnoea syndrome, Weight decreased, Conjunctivitis, Injection site pain, Dermatitis atopic, Pruritus, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1529 | 26775251 |
US |
1 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1530 | 26775254 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYCLOSPORINE, FINASTERIDE, FISH OIL, TIRZEPATIDE, ROSUVASTATIN, SERTRALINE, TADALAFIL, VITAMIN C, ERGOCALCIFEROL, |
||||
| 1531 | 26775264 |
US |
9 | 1 |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1532 | 26775275 |
US |
55 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1533 | 26775278 |
US |
14 | 2 |
Dermatitis atopic, Pruritus, Skin fissures, Skin irritation, |
||||
DUPILUMAB, |
||||
| 1534 | 26775463 |
US |
31 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Pruritus, Erythema, Dermatitis, Eye irritation, Insomnia, Eczema, Skin exfoliation, |
||||
DUPILUMAB, ERGOCALCIFEROL, VITAMIN C, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 1535 | 26775465 |
US |
13 | 1 |
Autism spectrum disorder, Pruritus, Mood disorder due to a general medical condition, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1536 | 26775471 |
US |
84 | 1 |
Dermatitis atopic, Pruritus, Sleep disorder due to general medical condition, insomnia type, |
||||
DUPILUMAB, |
||||
| 1537 | 26775703 |
US |
8 | 1 |
Dermatitis atopic, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1538 | 26775723 |
US |
44 | 2 |
Rash, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1539 | 26775891 |
US |
1 | |
Feeling abnormal, Measles, Blister, Thermal burn, Discomfort, Decreased appetite, Weight decreased, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1540 | 26775894 |
US |
1 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1541 | 26775897 |
US |
20 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1542 | 26776188 |
US |
22 | 2 |
Dermatitis atopic, Therapeutic product effect decreased, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROXYZINE, DIPHENHYDRAMINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 1543 | 26776189 |
US |
78 | 1 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1544 | 26776232 |
EG |
36 | 1 |
Corneal graft rejection, Dermatitis atopic, Drug ineffective, Pre-existing condition improved, Therapeutic response unexpected, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, AMLODIPINE BESYLATE AND VALSARTAN, |
||||
| 1545 | 26776266 |
US |
1 | |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 1546 | 26765303 |
US |
28 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1547 | 26765457 |
US |
12 | 2 |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1548 | 26765630 |
US |
21 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1549 | 26765873 |
US |
81 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1550 | 26765879 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1551 | 26765882 |
US |
29 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1552 | 26766171 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1553 | 26766192 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1554 | 26766200 |
US |
59 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1555 | 26766204 |
US |
23 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1556 | 26766440 |
US |
13 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1557 | 26766470 |
US |
67 | 2 |
Dermatitis atopic, Therapeutic response decreased, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1558 | 26766474 |
US |
19 | 2 |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, LEBRIKIZUMAB-LBKZ, |
||||
| 1559 | 26766770 |
US |
84 | 1 |
Productive cough, Dermatitis atopic, Dry eye, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1560 | 26767399 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1561 | 26767400 |
US |
9 | 2 |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, LORATADINE, LORATADINE ORAL, |
||||
| 1562 | 26767408 |
US |
81 | 2 |
Sinusitis, Insomnia, Candida infection, Dyspnoea, Vitamin D decreased, Injection site pain, Dermatitis atopic, Skin swelling, |
||||
DUPILUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, ALIROCUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1563 | 26767850 |
US |
1 | |
Dermatitis atopic, Product prescribing issue, |
||||
DUPILUMAB, |
||||
| 1564 | 26768253 |
US |
58 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1565 | 26768351 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1566 | 26768363 |
US |
11 | 2 |
Eye pain, Dry eye, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1567 | 26768366 |
US |
90 | 1 |
Dermatitis atopic, Pruritus, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1568 | 26768734 |
US |
5 | 1 |
Dermatitis atopic, Conjunctivitis, |
||||
DUPILUMAB, |
||||
| 1569 | 26768737 |
US |
2 | |
Eyelids pruritus, Swelling of eyelid, Erythema of eyelid, Dermatitis atopic, Conjunctivitis, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1570 | 26768738 |
US |
12 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1571 | 26768740 |
US |
69 | 1 |
Back pain, Dermatitis atopic, Skin laceration, |
||||
DUPILUMAB, |
||||
| 1572 | 26768746 |
US |
55 | 2 |
Dermatitis atopic, Pruritus, Eye irritation, Urinary tract disorder, Skin disorder, Vision blurred, Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1573 | 26768747 |
US |
72 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1574 | 26768757 |
US |
2 | |
Dermatitis atopic, Rash macular, Blood glucose abnormal, |
||||
DUPILUMAB, |
||||
| 1575 | 26768758 |
US |
53 | 2 |
Pruritus, Dry skin, Skin exfoliation, Dermatitis atopic, Therapeutic response shortened, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1576 | 26769137 |
US |
33 | 1 |
Skin discolouration, Dermatitis atopic, Therapeutic product effect incomplete, |
||||
DUPILUMAB, |
||||
| 1577 | 26769143 |
US |
1 | |
Nasal congestion, Skin depigmentation, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, CRISABOROLE, MOMETASONE FUROATE, MOMETASONE, EPINEPHRINE, ADRENALINUM, |
||||
| 1578 | 26769154 |
US |
7 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1579 | 26769156 |
US |
54 | 2 |
Dermatitis atopic, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1580 | 26769179 |
US |
67 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1581 | 26769547 |
US |
37 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1582 | 26769554 |
US |
29 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Haemorrhage, Skin weeping, Skin fissures, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1583 | 26769816 |
US |
20 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1584 | 26770023 |
US |
65 | 2 |
Dermatitis atopic, Rash erythematous, Dry skin, Pruritus, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1585 | 26770044 |
US |
2 | |
Hypersensitivity, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 1586 | 26770053 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1587 | 26770407 |
US |
12 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1588 | 26770632 |
US |
52 | 2 |
Seizure, Fatigue, Muscle spasms, Dermatitis atopic, Hyperhidrosis, Dyspepsia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 1589 | 26770709 |
US |
1 | |
Dermatitis atopic, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, RUXOLITINIB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, |
||||
| 1590 | 26770769 |
US |
25 | 2 |
Dermatitis atopic, Pruritus, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, |
||||
| 1591 | 26770773 |
US |
60 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1592 | 26770775 |
US |
9 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1593 | 26764153 |
US |
1 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1594 | 26764200 |
US |
62 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1595 | 26764235 |
US |
5 | 1 |
Multiple allergies, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1596 | 26764340 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1597 | 26764353 |
US |
64 | 1 |
Dermatitis atopic, Skin swelling, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1598 | 26764401 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1599 | 26764456 |
US |
9 | 1 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 1600 | 26764505 |
US |
41 | 2 |
Injection site urticaria, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30